Three CAR-T cell therapy studies announced from UK start-up Autolus – EPM Magazine
EPM Magazine |
Three CAR–T cell therapy studies announced from UK start-up Autolus
EPM Magazine AUTO2 and AUTO3 are both dual targeting CAR–T cell therapies. The announcement of the trials evaluating these two therapies comes on the back of the recent FDA approval of Novartis' CAR–T cell therapy, and Gilead's proposed acquisition of Kite Pharma … |
